BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19144364)

  • 21. Avian influenza A (H5N1) virus and 2 fundamental questions.
    Briand S; Fukuda K
    J Infect Dis; 2009 Jun; 199(12):1717-9. PubMed ID: 19416077
    [No Abstract]   [Full Text] [Related]  

  • 22. Avian influenza risk perception and live poultry purchase in Guangzhou, China, 2006.
    Liao Q; Lam WW; Jiang CQ; Ho EY; Liu YM; Zhang WS; Richard F
    Risk Anal; 2009 Mar; 29(3):416-24. PubMed ID: 19076328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert opinion based modelling of the risk of human infection with H5N1 through the consumption of poultry meat in Germany.
    Greiner M; Müller-Graf C; Hiller P; Schrader C; Gervelmeyer A; Ellerbroek L; Appel B
    Berl Munch Tierarztl Wochenschr; 2007; 120(3-4):98-107. PubMed ID: 17416131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A network model of H5N1 avian influenza transmission dynamics in domestic cats.
    Ayyalasomayajula S; DeLaurentis DA; Moore GE; Glickman LT
    Zoonoses Public Health; 2008 Oct; 55(8-10):497-506. PubMed ID: 18631233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilemmas of securitization and health risk management in the People's Republic of China: the cases of SARS and avian influenza.
    Wishnick E
    Health Policy Plan; 2010 Nov; 25(6):454-66. PubMed ID: 20961946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.
    Belser JA; Szretter KJ; Katz JM; Tumpey TM
    Adv Virus Res; 2009; 73():55-97. PubMed ID: 19695381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H5N1 avian influenza in children.
    Oner AF; Dogan N; Gasimov V; Adisasmito W; Coker R; Chan PK; Lee N; Tsang O; Hanshaoworakul W; Zaman M; Bamgboye E; Swenson A; Toovey S; Dreyer NA
    Clin Infect Dis; 2012 Jul; 55(1):26-32. PubMed ID: 22423125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influenza vaccine: globalization of public health stakes].
    Collin N; Briand S
    Med Trop (Mars); 2009 Aug; 69(4):322. PubMed ID: 19725377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expert judgments of pandemic influenza risks.
    Bruine De Bruin W; Fischhoff B; Brilliant L; Caruso D
    Glob Public Health; 2006; 1(2):178-93. PubMed ID: 19153906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatio-temporal epidemiology of highly pathogenic avian influenza outbreaks in the two deltas of Vietnam during 2003-2007.
    Minh PQ; Morris RS; Schauer B; Stevenson M; Benschop J; Nam HV; Jackson R
    Prev Vet Med; 2009 May; 89(1-2):16-24. PubMed ID: 19232765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Contribution of simulation models to public health decisions: the influenza pandemic].
    Bonmarin I; Levy-Bruhl D
    Med Mal Infect; 2007 Dec; 37 Suppl 3():S204-9. PubMed ID: 18031963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
    Collin N; de Radiguès X;
    Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevention and control of infectious diseases with pandemic potential: the EU-project SARSControl].
    Ahmad A; Krumkamp R; Richardus JH; Reintjes R
    Gesundheitswesen; 2009 Jun; 71(6):351-7. PubMed ID: 19530059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.
    Kreijtz JH; Bodewes R; van den Brand JM; de Mutsert G; Baas C; van Amerongen G; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2009 Aug; 27(36):4983-9. PubMed ID: 19538996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular evolution of H5N1 in Thailand between 2004 and 2008.
    Suwannakarn K; Amonsin A; Sasipreeyajan J; Kitikoon P; Tantilertcharoen R; Parchariyanon S; Chaisingh A; Nuansrichay B; Songserm T; Theamboonlers A; Poovorawan Y
    Infect Genet Evol; 2009 Sep; 9(5):896-902. PubMed ID: 19539056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor.
    Higgs ES; Hayden FG; Chotpitayasunondh T; Whitworth J; Farrar J
    Antiviral Res; 2008 Apr; 78(1):64-8. PubMed ID: 18295355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and anticipated behavior of health care workers in response to an outbreak of pandemic influenza in Georgia.
    Butsashvili M; Triner W; Kamkamidze G; Kajaia M; McNutt LA
    J Infect Dev Ctries; 2007 Dec; 1(3):329-32. PubMed ID: 19734614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronological, geographical, and seasonal trends of human cases of avian influenza A (H5N1) in Vietnam, 2003-2014: a spatial analysis.
    Manabe T; Yamaoka K; Tango T; Binh NG; Co DX; Tuan ND; Izumi S; Takasaki J; Chau NQ; Kudo K
    BMC Infect Dis; 2016 Feb; 16():64. PubMed ID: 26847341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial and temporal dynamics of influenza outbreaks.
    Onozuka D; Hagihara A
    Epidemiology; 2008 Nov; 19(6):824-8. PubMed ID: 18813019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.